Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: David L. Fischman
4
Mins
April 2024
With over 20 years of experience as a cardiologist, what initially sparked your interest in the field, and continues to motivate you at…
Read more
7
Mins
14th December 2020
Looking PHorward to Improving Long-Term Outcomes in Pulmonary Arterial Hypertension
PH encompasses a heterogeneous group of conditions, including PAH (Group 1), PH due to LHD (Group 2), PH due to lung diseases and/or hypoxia…
5
Mins
10th December 2020
Surrounding Advanced Heart Failure: The Role of the Latest Left Ventricular Assist Devices
Advanced stage heart failure accounts for 1-10% of the overall heart failure population and the prevalence is increasing, in part because of…
8
Mins
20th October 2020
Therapeutic Advances in Patients with Heart Failure with Reduced Ejection Fraction Who Have Had a Previous Worsening Heart Failure Event
European and USA treatment guidelines are aligned in their standard recommendation of therapies for symptomatic HFrEF. First-line…
8
Mins
20th October 2020
New Insights into Icosapent Ethyl for Patients with Residual Cardiovascular Risk
REDUCE-IT was a Phase IIIb, double-blind, placebo-controlled trial that randomised 8,179 patients to receive icosapent ethyl (4 g/day) or placebo…
2
Mins
20th October 2020
First Clinical Validation of the 0-Hour/1-Hour Algorithm Using High-Sensitivity Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction in Japanese Patients
Acute myocardial infarction (AMI) is a common and life-threating condition. Approximately 10% of all emergency department (ED)…
5
Mins
20th October 2020
Key Findings from the EXPLORER-HCM Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy: Insights From the Principal Investigator
Hypertrophic cardiomyopathy (HCM) is a progressive myocardial disease that impacts function and quality of life. Patients…
4
Mins
20th October 2020
Interview: Dr Rasha Al-Lamee
I went into cardiology to combine the science of medicine and the practical skills of surgery. I enjoy finding a problem and doing my best to fix it…
10
Mins
20th October 2020
Editor’s Pick: Artificial Intelligence in Patients with Congenital Heart Disease: Where Do We Stand?
Life expectancy of patients with congenital heart disease (CHD) has increased in recent decades; however, late complications remain frequent and…
Loading posts...
« Previous
1
…
6
7
8
9
10
…
22
Next »